Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TacroBell SR in Kidney Transplant Recipients
NCT03749356Phase 4Completed
- Sponsor
- Chong Kun Dang Holdings
- Start
- Sep 2018
- Primary completion
- Jul 2020
- Modality
- RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tacrolimus in kidney transplant rejection, sponsored by Chong Kun Dang Holdings. Started Sep 2018; status: completed.
02
Drugs
tacrolimus
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT03749356.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03749356.